{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T11:25:05Z","timestamp":1788866705565,"version":"build-2803163510"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy &amp; Behavior"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.yebeh.2016.04.030","type":"journal-article","created":{"date-parts":[[2016,5,18]],"date-time":"2016-05-18T02:46:13Z","timestamp":1463539573000},"page":"138-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital"],"prefix":"10.1016","volume":"60","author":[{"given":"Elias A.","family":"Shaaya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia R.","family":"Grocott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Laing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L.","family":"Thibert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2016.04.030_bb0005","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1469-8749.1965.tb07844.x","article-title":"\u201cPuppet\u201d children. A report on three cases","volume":"7","author":"Angelman","year":"1965","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2016.04.030_bb0010","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ajmg.a.33775","article-title":"Angelman syndrome: mutations influence features in early childhood","volume":"155A","author":"Tan","year":"2011","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.yebeh.2016.04.030_bb0015","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ajmg.1320320235","article-title":"Angelman and Prader\u2013Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion","volume":"32","author":"Knoll","year":"1989","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.yebeh.2016.04.030_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ng0997-75","article-title":"Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons","volume":"17","author":"Albrecht","year":"1997","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.yebeh.2016.04.030_bb0025","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0197-70","article-title":"UBE3A\/E6-AP mutations cause Angelman syndrome","volume":"15","author":"Kishino","year":"1997","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.yebeh.2016.04.030_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/ajmg.1316","article-title":"Angelman syndrome: mimicking conditions and phenotypes","volume":"101","author":"Williams","year":"2001","journal-title":"Am J Med Genet"},{"issue":"11","key":"10.1016\/j.yebeh.2016.04.030_bb0035","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1111\/j.1528-1167.2009.02108.x","article-title":"Epilepsy in Angelman syndrome: a questionnaire-based assessment of the natural history and current treatment options","volume":"50","author":"Thibert","year":"2009","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2016.04.030_bb0040","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/ajmg.a.36416","article-title":"2014. If not Angelman, what is it? A review of Angelman-like syndromes","volume":"165","author":"Tan","year":"2014","journal-title":"Am J Med Genet A"},{"issue":"2","key":"10.1016\/j.yebeh.2016.04.030_bb0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1528-1157.1997.tb01097.x","article-title":"Evolution of epilepsy and EEG findings in Angelman syndrome","volume":"38","author":"Laan","year":"1997","journal-title":"Epilepsia"},{"issue":"5","key":"10.1016\/j.yebeh.2016.04.030_bb0050","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/adc.79.5.423","article-title":"Parental view of epilepsy in Angelman syndrome: a questionnaire study","volume":"79","author":"Ruggieri","year":"1998","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.yebeh.2016.04.030_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1684\/j.1950-6945.2005.tb00095.x","article-title":"Analysis of the characteristics of epilepsy in 37 patients with the molecular diagnosis of Angelman syndrome","volume":"7","author":"Galvan-Manso","year":"2005","journal-title":"Epileptic Disord"},{"issue":"5","key":"10.1016\/j.yebeh.2016.04.030_bb0060","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/ajmg.a.31074","article-title":"Angelman syndrome 2005: updated consensus for diagnostic criteria","volume":"140","author":"Williams","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"3","key":"10.1016\/j.yebeh.2016.04.030_bb0065","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/(SICI)1096-8628(19961218)66:3<356::AID-AJMG21>3.0.CO;2-K","article-title":"2014. Angelman syndrome in adulthood","volume":"66","author":"Larson","year":"1996","journal-title":"Am J Med Genet A"},{"issue":"10","key":"10.1016\/j.yebeh.2016.04.030_bb0070","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1017\/S0012162201001293","article-title":"Efficacy of different antiepileptic drugs in children with Angelman syndrome associated with 15q11-13 deletion: the Danish experience","volume":"43","author":"Ostergaard","year":"2001","journal-title":"Dev Med Child Neurol"},{"issue":"24","key":"10.1016\/j.yebeh.2016.04.030_bb0075","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1093\/ajhp\/60.24.2583","article-title":"Assessment of anticonvulsant effectiveness and safety in patients with Angelman's syndrome using an internet questionnaire","volume":"60","author":"Nolt","year":"2003","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.yebeh.2016.04.030_bb0080","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archneur.63.1.122","article-title":"Epilepsy in patients with Angelman syndrome caused by deletion of the chromosome 15q11-13","volume":"63","author":"Valente","year":"2006","journal-title":"Arch Neurol"},{"issue":"5","key":"10.1016\/j.yebeh.2016.04.030_bb0085","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.nrl.0000253067.32759.aa","article-title":"Angelman syndrome revisited","volume":"13","author":"Paprocka","year":"2007","journal-title":"Neurologist"},{"issue":"3","key":"10.1016\/j.yebeh.2016.04.030_bb0090","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/phar.1201","article-title":"Neurogenetic disorders and treatment of associated seizures","volume":"33","author":"Faulkner","year":"2013","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.yebeh.2016.04.030_bb0095","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.seizure.2014.06.004","article-title":"Behavioral side effects of levetiracetam in children with epilepsy: a systematic review","volume":"23","author":"Halma","year":"2014","journal-title":"Seizure"},{"issue":"3","key":"10.1016\/j.yebeh.2016.04.030_bb0100","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1528-1167.2006.00969.x","article-title":"Lamotrigine therapy of epilepsy with Angelman's syndrome","volume":"48","author":"Dion","year":"2007","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.yebeh.2016.04.030_bb0105","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/11599020-000000000-00000","article-title":"GABA(A) receptor physiology and its relationship to the mechanism of action of the 1,5-benzodiazepine clobazam","volume":"26","author":"Sankar","year":"2012","journal-title":"CNS Drugs"},{"issue":"3","key":"10.1016\/j.yebeh.2016.04.030_bb0110","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neulet.2010.08.001","article-title":"Altered GABAA receptor subunit expression and pharmacology in human Angelman syndrome cortex","volume":"483","author":"Roden","year":"2010","journal-title":"Neurosci Lett"},{"issue":"9","key":"10.1016\/j.yebeh.2016.04.030_bb0115","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1528-1167.2012.03537.x","article-title":"Low glycemic index treatment for seizures in Angelman syndrome","volume":"53","author":"Thibert","year":"2012","journal-title":"Epilepsia"}],"container-title":["Epilepsy &amp; Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501630052X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501630052X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,16]],"date-time":"2024-06-16T12:20:12Z","timestamp":1718540412000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501630052X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":23,"alternative-id":["S152550501630052X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.04.030","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Seizure treatment in Angelman syndrome: A case series from the Angelman Syndrome Clinic at Massachusetts General Hospital","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2016.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}